Breast cancer treatment planning & oncology. Agendia's genomic tests provide you with actionable insights through the patient’s breast cancer journey.
Kevin R. Fox, MD, Medical Director, Rena Rowan Breast Center, University of Pennsylvania, Abramson Cancer Center, discusses the role of genomic testing for women with early-stage breast cancer with positive lymph node status, a concept that is already widely accepted for women that are node-neg...
Genomic Test for Breast Cancer Recurrence Found to be Cost-EffectiveSteven LewisHealthcarepapers
EP: 2.Overview of Genomic Assays for Early-Stage Breast Cancer EP: 3.MammaPrint: A 70-Gene Signature Test for Patient with Breast Cancer Now Viewing EP: 4.Clinical Considerations of Genomic Testing in Early-Stage Breast Cancer EP: 5.FLEX Trial: Genomic Testing of HER2 Status in ER+/HER2-...
Once you have decided on our breast cancer genomic testing - MammaPrint can be ordered alone or in combination with BluePrint.
First published:16 March 2017 https://doi.org/10.1002/bjs.10513 Citations:2 Read thefull text PDF Tools Share Abstract Makes a real difference References Citing Literature Volume104,Issue7 June 2017 Pages799-801 References Related Information ...
Patritumab deruxtecan (HER3-DXd) is a promising therapy for breast cancer, targeting HER3. Here, the authors analyse the genomic factors that affect the response to HER3-DXd in patients with early-stage HER2-negative breast cancer as part of the SOLTI-1805 TOT-HER3 clinical trial and repo...
ORDER TESTS Region:United States Breast Cancer Turnwhat if intowhat is. The Oncotype DX Breast Recurrence Score®test provides personalized genomic insights for early-stage HR+, HER2- breast cancer patients. The only test proven to predict likelihood of chemotherapy benefit1,2 ...
in the genes that people inherit from their parents. It is different from genomic tumor tests that look at specific genes or proteins in the cancer cells and can help doctors understand the rate at which the cancer cells are dividing, for example, and the likelihood of a cancer recurrence.)...
The impact of age on the use of adjuvant chemotherapy in the era of genomic tests. A literature search was conducted in the MEDLINE, EMBASE, and CENTRAL databases from their inception up to October 3, 2019 using the following keywords: “breast cancer” or its synonyms “breast carcinoma”,...